Short Interest in Click Holdings Limited (NASDAQ:CLIK) Declines By 29.1%

Click Holdings Limited (NASDAQ:CLIK) was the target of a significant decrease in short interest in December. As of December 15th, there was short interest totaling 9,893 shares, a decrease of 29.1% from the November 30th total of 13,952 shares. Based on an average trading volume of 89,670 shares, the short-interest ratio is presently 0.1 days. Currently, 0.9% of the shares of the company are short sold. Currently, 0.9% of the shares of the company are short sold. Based on an average trading volume of 89,670 shares, the short-interest ratio is presently 0.1 days.

Wall Street Analyst Weigh In

Separately, Weiss Ratings reiterated a “sell (d)” rating on shares of Click in a research note on Monday, December 22nd. One investment analyst has rated the stock with a Sell rating, According to MarketBeat.com, Click currently has a consensus rating of “Sell”.

Click Stock Down 0.5%

CLIK opened at $5.63 on Monday. Click has a twelve month low of $4.80 and a twelve month high of $102.90. The company has a 50-day simple moving average of $6.46 and a 200 day simple moving average of $9.09.

Click Company Profile

Click Therapeutics, Inc (NASDAQ: CLIK) is a clinical-stage digital therapeutics company developing software-based treatments for neurological, psychiatric and chronic diseases. Its platform delivers prescription digital therapies via mobile and web applications, combining evidence-based cognitive behavioral interventions, digital monitoring tools and patient engagement techniques. Click’s approach is designed to complement or extend traditional pharmacological and behavioral treatments for conditions such as major depressive disorder, insomnia and tobacco use disorder.

Founded in 2014, Click has progressed multiple programs through randomized controlled trials and regulatory review.